Recently an internal memo dated April 17, 2013, issued by the Food and Drug Administration’s Center Drug Evaluation and Research, Office of Surveillance and Epidemiology, was obtained through the freedom of information act shows the FQs in a damning light.
Yearly Archive: 2014
A simple three step action that logically links FQ’s to the ability to initiate delayed adverse “late effect” reactions. There are no grand leaps of faith or conjecture required to link the steps.
Hacking’ is a positive term. The mission is to energize and connect the best minds in the fluoroquinolone community to vet out truth from fiction, what works from what does not, cut through all the noise on the web to single out reliable information, regardless of the source.
Theoretically, the use of pharmaceuticals, even those that are not designated antibiotics, can exert negative influences on your body’s microbiome and contribute to antibiotic resistance.
Since our physiology is not static and things such as enzyme levels and trace mineral are in a constant state of flux, not to mention genetic variances, all which affect metabolization, combined with the fact that the FQ molecule is very complex, there is no way of determining if the same decomposed and identifiable compound will form an adduct in each person.
Have you taken a fluoroquinolone antibiotic such as Cipro (ciprofloxacin), Levaquin (levofloxacin), or Avelox (moxifloxacin)? Would you be willing to help in a survey-based medical research study?
I would have to say that we are one of the most complex subset of patients that can be seen by a physician. More often than not, we often leave the average physician scratching his head as to how to diagnose or treat our condition. Keeping that context in mind, I have determined that I will never see another nurse practitioner again.